Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
08/05/2025
Hong Kong stocks' innovative drug sector fell at the beginning of trading, BeiGene fell more than 6%, Rongchang Biology fell more than 5%, Sinopharm Biological, China Medical Biology, and Junshi Biology all fell.
Latest
3 m ago
Ford raises prices of cars produced in Mexico, citing tariffs.
3 m ago
Ford Motor Company has raised the prices of three models produced in Mexico starting from May 2, becoming one of the first major automakers to adjust sticker prices after US President Trump announced the imposition of tariffs. According to a notice sent to dealers, prices for certain models of the Mustang Mach-E electric SUV, Maverick pick-up, and Bronco Sport will increase by up to $2000.
5 m ago
J.P. Morgan Securities: Maintains rating on Dynavax Technologies (DVAX.US) from Outperform to Overweight, with a target price adjustment from $33.00 to $31.00.
6 m ago
Goldman Sachs: Maintains a Buy rating on IAC (IAC.US), adjusting the target price from $60.00 to $46.00.
8 m ago
Wedbush: Maintains rating for Electronic Arts (EA.US) from outperform to outperform, with price target adjusted from $179.00 to $210.00.
See all latest